Acyclovir vs Durvalumab

## Acyclovir vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Acyclovir** and **Durvalumab**.

## Mechanism of Action

**Acyclovir**: Guanosine analogue inhibiting viral DNA polymerase.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Acyclovir — 2.5-3.3 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Acyclovir — C8H11N5O3; Durvalumab — N/A.

**Molecular Weight**: Acyclovir — 225.2050 g/mol; Durvalumab — N/A.

**Type**: Acyclovir — Small molecule; Durvalumab — Antibody.